| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 6 |
| 1 | LAMIVUDINE ORAL | 6 |
| 2 | ZIDOVUDINE | 6 |
| 3 | RALTEGRAVIR | 4 |
| 4 | RILPIVIRINE | 3 |
| 5 | ABACAVIR | 2 |
| 6 | ABACAVIR SULFATE | 2 |
| 7 | CABOTEGRAVIR SODIUM | 2 |
| 8 | EMTRICITABINE | 2 |
| 9 | LOPINAVIR AND RITONAVIR | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CABOTEGRAVIR SODIUM | 2 | 0.0012 |
| 1 | RALTEGRAVIR | 4 | 0.0008 |
| 2 | ZIDOVUDINE | 6 | 0.0006 |
| 3 | AMPHETAMINE SULFATE TABLETS | 1 | 0.0006 |
| 4 | RILPIVIRINE | 3 | 0.0004 |
| 5 | LAMIVUDINE | 6 | 0.0002 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 2 | 0.0002 |
| 7 | NEVIRAPINE | 2 | 0.0002 |
| 8 | ABACAVIR SULFATE | 2 | 0.0002 |
| 9 | LOPINAVIR AND RITONAVIR | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Protease Inhibitor [EPC] | 2 | 0.0000 |